Psychotic Disorders (cont.)

Medical Author:
Medical Editor:

What are complications of psychotic disorders?

That men seem to develop these illnesses at younger ages may contribute to men having more episodes of the illness that are more severe compared to women.

What is the prognosis for people with a psychotic disorder?

While more than two-thirds of people who have a psychotic disorder may suffer a return of those symptoms sometime, the combination of medications, psychosocial treatment, and education of the psychotic disorder sufferer and their loved ones tends to greatly improve how well the person is able to function. The shorter the amount of time from when the person begins having psychotic symptoms to when comprehensive treatment begins, the better the prognosis.

Can psychotic disorders be prevented?

Cognitive behavioral therapy (CBT) for the person who is at high risk for developing psychosis but has yet to have such symptoms has been found to be more effective than medication at preventing such symptoms. In individuals who have developed psychotic symptoms, providing his or her family with support and education about their loved one's condition have been found to be quite helpful in the prevention of the recurrence of psychotic symptoms in the individual with the illness. For women who have developed postpartum psychosis in the past, preterm delivery of subsequent pregnancy has been found to help prevent further episodes of the disorder.

Where can people find additional information about psychotic disorders?

Action Postpartum Psychosis
Tel: 0292 074 2038

American Psychological Association

American Psychiatric Association

National Alliance for the Mentally Ill (NAMI)

National Mental Health Association

Postpartum Support International

Schizophrenics Anonymous


Bartholomeusz CF, Allott K. Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: Theoretical considerations and current state of evidence. Schizophrenia Research and Treatment 2012.

Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine 2002; 763-782.

Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk. Archives of General Psychiatry 2008; 65: 28-37.

Cornblatt BA, Carrion RE, Addington J, Seidman L, Walker EF, et al. Risk factors for psychosis: Impaired social and role functioning. Schizophrenia Bulletin 2012; 38(6): 1247-1257.

Das-Munshi J, Becares L, Boydell JE, Dewey ME, et al. Ethnic density as a buffer for psychotic experiences: findings from a national survey (EMPIRIC). British Journal of Psychiatry 2012 October; 201: 282-290.

Dvir Y, Frazier JA. Autism and schizophrenia. Psychiatric Times 2011; 28(3).

Honey GD, Corlett PR, Absalom AR, Lee M, et al. Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. Journal of Neuroscience 2008 June; 62-95-6303.

Jenkins R, Njenga F, Okonji M, Kigamwa P, et al. Psychotic symptoms in Kenya – prevalence, risk factors, and relationship with common mental disorders. International Journal of Environmental Research in Public Health 2012; 9(5): 1748-1756.

Malone DT, Hill MN, Rubino T. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. British Journal of Pharmacology 2010 June; 160(3): 511-522.

Nau ML, McNiel DE, Binder RL. Postpartum psychosis and the courts. Journal of the American Academy of Psychiatry and the Law 2012 September; 40(3): 318-325.

Nuevo R, et al. The continuum of psychotic symptoms in the general population: a cross-national study. Schizophrenia Bulletin 2012; 38: 475-485.

Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review. Schizophrenia Research and Treatment 2012.

Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: a systemic review. Journal of Psychopharmacology 2005; 19(2): 187-194.

Shrivastava A, McGorry PD, Tsuang M, Woods SW, et al. “Attenuated psychotic symptoms syndrome" as a risk syndrome of psychosis, diagnosis in DSM-V: The debate. Indian Journal of Psychiatry 2011 Jan-Mar; 53(1): 57-65.

Singh SP. Outcome measures in early psychosis: Relevance of duration of untreated psychosis. British Journal of Psychiatry 2007.

Stafford MR et al. Early interventions to prevent psychosis: systematic review and meta-analysis. British Medical Journal 2013 January; 346.

Suvisaari JM, Taxell-Lassas V, Pankakoski M, et al. Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophrenia Bulletin 2012.

Terp IM, Engholm G, Mller H, Mortensen PB. A follow-up study of postpartum psychoses: prognosis and risk factors for readmission. Acta Psychiatry of Scandinavia 1999: 100: 40–46.

Valencia M, Juarez F, Ortega H. Integrated treatment to achieve functional recovery for first-episode psychosis. Schizophrenia Research and Treatment 2012.

Varese F, Smeets F, Drukker M, Lieverse R, et al. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective – and cross-sectional cohort studies. Schizophrenia Bulletin 2012.

Wiles NJ, Zammit S, Bebbington P, Singleton N, et al. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. British Journal of Psychiatry 2006; 188: 519-526.

Medically Reviewed by a Doctor on 5/1/2013

Patient Comments

Viewers share their comments

Psychotic Disorders - Experience Question: What type of psychotic disorder do you have? Describe your experience.
Psychotic Disorders - Treatments Question: What treatment did you receive for your psychotic disorder?
Psychotic Disorders - Symptoms Question: What were the symptoms of your psychotic disorder?


Get the Latest health and medical information delivered direct to your inbox!